DermTech, Inc.
DMTKQ
$0.00
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.58% | 31.06% | 9.57% | -5.98% | -6.48% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.58% | 31.06% | 9.57% | -5.98% | -6.48% |
| Cost of Revenue | -18.03% | 4.00% | 1.33% | 21.36% | 7.51% |
| Gross Profit | 307.27% | 223.60% | 242.15% | -99.17% | -309.76% |
| SG&A Expenses | -34.21% | -28.10% | -30.08% | -4.72% | 13.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -31.44% | -25.72% | -27.74% | -10.14% | 4.76% |
| Operating Income | 36.00% | 31.60% | 32.30% | 10.73% | -6.14% |
| Income Before Tax | 36.01% | 32.36% | 33.39% | -6.03% | -3.86% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 36.01% | 32.36% | 33.39% | -6.03% | -3.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.01% | 32.36% | 33.39% | -6.03% | -3.86% |
| EBIT | 36.00% | 31.60% | 32.30% | 10.73% | -6.14% |
| EBITDA | 36.61% | 32.08% | 32.86% | 11.13% | -5.90% |
| EPS Basic | 43.66% | 40.39% | 40.75% | 0.07% | -1.41% |
| Normalized Basic EPS | 43.67% | 40.40% | 40.75% | 17.60% | -1.41% |
| EPS Diluted | 43.32% | 40.39% | 40.63% | 0.00% | -1.32% |
| Normalized Diluted EPS | 43.67% | 40.40% | 40.75% | 17.60% | -1.41% |
| Average Basic Shares Outstanding | 13.58% | 13.49% | 12.42% | 6.10% | 2.42% |
| Average Diluted Shares Outstanding | 13.58% | 13.49% | 12.42% | 6.10% | 2.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |